platinum has been researched along with Astrocytoma, Grade IV in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 9 (56.25) | 2.80 |
| Authors | Studies |
|---|---|
| Boukos, N; Chalmpes, N; Corral, CA; Efthimiadou, EK; Gobbo, OL; Gournis, D; Papanastasiou, G; Sakellis, E; Stavropoulou, AP; Tavares, A; Theodosiou, M; Wang, C | 1 |
| Boehm, D; Bourke, P; Cullen, PJ; Curtin, J; Gunes, S; He, Z; Malone, R; Ng, SW; Pinheiro Lopes, B; Tsoukou, E; Wang, W | 1 |
| Aldrich-Wright, JR; Aputen, AD; Elias, MG; Gilbert, J; Gordon, CP; Sakoff, JA; Scott, KF | 1 |
| Berger, G; Cho, CF; Farquhar, CE; Fedeles, BI; Finkelberg, T; Jimenez-Macias, JL; Lawler, SE; Lee, YC; Loas, A; Miller, E; Nowicki, MO; Pentelute, BL; Zdioruk, M | 1 |
| Achard, T; Bellemin-Laponnaz, S; de Larrinoa, PF; Dontenwill, M; Fournel, S; Frisch, B; Herold-Mende, C; Heurtault, B; Kichler, A; Parmentier, J | 1 |
| Bartomeu Garcia, C; López Ruiz, A; Navarro Gallón, S; Webster, TJ | 1 |
| An, JM; Ju, Y; Jung, Y; Kim, D; Kim, J; Kim, JH; Kim, YJ; Lee, H | 1 |
| Chan, MH; Chang, YC; Chen, W; Fang, CY; Hsiao, M; Li, CH; Liu, RS; Wei, DH | 1 |
| Kato, S | 1 |
| Avril, S; Boury, F; Garcion, E; Hindré, F; Jérôme, C; Lajous, H; Lecomte, P; Lelièvre, B; Riva, R; Tétaud, C | 1 |
| Pandey, A; Patel, K; Patel, S; Sawant, K; Singh, K; Singh, R | 1 |
| Aroui, S; Dardevet, L; De Waard, M; Fetoui, H; Kammoun, M; Kenani, A; Laajimi, A; Najlaoui, F | 1 |
| Albaladejo, J; Alonso-Moreno, C; Bravo, I; Carrillo-Hermosilla, F; Ceña, V; Garzón, A; López-Solera, I; Posadas, I; Villaseca, N | 1 |
| Alvarez, M; Guevara, P; López, T; Odriozola, JA; Recillas, S; Sotelo, J | 1 |
| Anderson, JG; Bierbach, U; Hess, SM | 1 |
| Amemiya, Y; Hattori, K; Kida, Y; Kobayashi, T; Matsui, M; Tanaka, T | 1 |
16 other study(ies) available for platinum and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Bimetallic gold-platinum nanoparticles as a drug delivery system coated with a new drug to target glioblastoma.
Topics: Drug Delivery Systems; Glioblastoma; Gold; HEK293 Cells; Humans; Metal Nanoparticles; Platinum | 2022 |
Cell death induced in glioblastoma cells by Plasma-Activated-Liquids (PAL) is primarily mediated by membrane lipid peroxidation and not ROS influx.
Topics: Antioxidants; Cell Death; Glioblastoma; Humans; Lipid Peroxidation; Lipids; Metal Nanoparticles; Nitrogen; Oxygen; Plasma Gases; Platinum; Reactive Oxygen Species | 2022 |
Bioactive Platinum(IV) Complexes Incorporating Halogenated Phenylacetates.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Female; Glioblastoma; Humans; Ovarian Neoplasms; Phenylacetates; Platinum; Reactive Oxygen Species | 2022 |
A Pt(IV)-conjugated brain penetrant macrocyclic peptide shows pre-clinical efficacy in glioblastoma.
Topics: Animals; Antineoplastic Agents; Brain; Cell Line, Tumor; Cisplatin; Glioblastoma; Humans; Mice; Mice, Nude; Peptides; Platinum; Prodrugs; Treatment Outcome | 2022 |
Triphenylphosphonium-functionalized N-heterocyclic carbene platinum complexes [(NHC-TPP
Topics: Antineoplastic Agents; Cell Death; Cell Line, Tumor; Glioblastoma; Humans; Platinum | 2023 |
Novel Silver-Platinum Nanoparticles for Anticancer and Antimicrobial Applications.
Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Escherichia coli; Glioblastoma; Humans; Melanoma; Metal Nanoparticles; Microbial Sensitivity Tests; Platinum; Pseudomonas aeruginosa; Silver; Staphylococcus aureus | 2020 |
A metastasis suppressor Pt-dendrimer nanozyme for the alleviation of glioblastoma.
Topics: Actins; Cell Adhesion; Cell Line, Tumor; Cell Movement; Dendrimers; Glioblastoma; Humans; Hydrogen Peroxide; Metal Nanoparticles; Platinum; RNA, Messenger | 2021 |
An Advanced
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Blood-Brain Barrier; Brain Neoplasms; Cell Proliferation; Doxorubicin; Drug Delivery Systems; Glioblastoma; Humans; Iron; Magnetic Resonance Imaging; Metal Nanoparticles; Mice; Nanocomposites; Platinum; Precision Medicine; Tumor Cells, Cultured; Ultrasonics; Xenograft Model Antitumor Assays | 2021 |
Effects of platinum-coexisting dopamine with X-ray irradiation upon human glioblastoma cell proliferation.
Topics: Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Combined Modality Therapy; Dopamine; Drug Combinations; Glioblastoma; Humans; Mitosis; Nanoparticles; Neurotransmitter Agents; Phenethylamines; Platinum; Radiation Dosage; Reactive Oxygen Species; Temozolomide; X-Rays | 2021 |
Hybrid Gd
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cisplatin; DNA Adducts; Drug Liberation; Female; Gadolinium DTPA; Glioblastoma; Mice, Nude; Nanoparticles; Platinum; Polycarboxylate Cement; Polyesters; Polyethylene Glycols; Prodrugs | 2018 |
Hyaluronic acid tethered pH-responsive alloy-drug nanoconjugates for multimodal therapy of glioblastoma: An intranasal route approach.
Topics: Administration, Intranasal; Alloys; Animals; Blood-Brain Barrier; Cell Line, Tumor; Cell Survival; Dogs; Drug Liberation; Endocytosis; Glioblastoma; Humans; Hyaluronic Acid; Hydrogen-Ion Concentration; Hyperthermia, Induced; Iron; Lactoferrin; Lenalidomide; Male; Mucins; Nanoconjugates; Oleic Acid; Photoelectron Spectroscopy; Phototherapy; Platinum; Rats, Wistar; Reactive Oxygen Species; Spectroscopy, Fourier Transform Infrared; Swine | 2019 |
PTEN-regulated AKT/FoxO3a/Bim signaling contributes to Human cell glioblastoma apoptosis by platinum-maurocalcin conjugate.
Topics: Apoptosis; Bcl-2-Like Protein 11; Cell Line, Tumor; Forkhead Box Protein O3; Glioblastoma; Humans; Platinum; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Scorpion Venoms; Signal Transduction; Up-Regulation | 2016 |
Synthesis, characterization, DNA interactions and antiproliferative activity on glioblastoma of iminopyridine platinum(II) chelate complexes.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coordination Complexes; Crystallography, X-Ray; DNA; Glioblastoma; Imines; Molecular Structure; Platinum; Pyridines; Rats | 2017 |
Pt/TiO2 brain biocompatible nanoparticles: GBM treatment using the C6 model in Wistar rats.
Topics: Animals; Biocompatible Materials; Brain Neoplasms; Cell Line, Tumor; Drug Carriers; Glioblastoma; Male; Micelles; Nanoparticles; Phase Transition; Platinum; Rats; Rats, Wistar; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Titanium | 2008 |
A non-crosslinking platinum-acridine hybrid agent shows enhanced cytotoxicity compared to clinical BCNU and cisplatin in glioblastoma cells.
Topics: Acridines; Animals; Carmustine; Caspase 3; Caspases; Cell Line; Cisplatin; Cross-Linking Reagents; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Glioblastoma; Inhibitory Concentration 50; Organoplatinum Compounds; Platinum | 2005 |
Interstitial hyperthermia of malignant brain tumors by implant heating system: clinical experience.
Topics: Brain Neoplasms; Breast Neoplasms; Combined Modality Therapy; Equipment Design; Glioblastoma; Glioma; Humans; Hyperthermia, Induced; Iron; Microwaves; Necrosis; Platinum; Prostheses and Implants; Stereotaxic Techniques | 1991 |